What I am saying, she should have delivered what she could and promise to devliver better in the feature instead of failing to deliver on the promises.
She could have bought a small manufacturer with all that funding, slap a nice UI and iOT functions on top of it and deliver that. Continue to work on the original 1 drop of blood tests, maybe integrate it into the more expensive version of the machines of the manufacturer she bought, call it beta and use on own risk and the accurate version will be enabled through software update in the future.
Also, being funny on twitter could have been better strategy than imitating Steve Jobs.